Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

HBI Deals+Insights briefing May 2026: Deals + Insights members

HBI’s May 2026 edition looks at global healthcare deals including Barmer partnering with Hello Inside, Affidea leaving Hungary, Doctolib buying Medicus and expanding into the UK, Medtronic investing in Pulnovo, among others. plus interviews and HBI 2026 post-conference write-ups.
May 13, 2026

HBI Deals+Insights briefing May 2026: Intelligence members

HBI’s May 2026 edition looks at global healthcare deals including Barmer partnering with Hello Inside, Affidea leaving Hungary, Doctolib buying Medicus and expanding into the UK, Medtronic investing in Pulnovo, among others. plus interviews and HBI 2026 post-conference write-ups.
May 13, 2026

ArchiMed to take Esperion private for ~$1 billion

French private equity firm ArchiMed is taking Nasdaq-listed commercial biopharma firm Esperion Therapeutics private for ~$1 billion. Esperion develops cardiometabolic and rare/orphan disease therapies.
May 8, 2026

Carlyle acquires Knack RCM and EqualizeRCM

US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.
May 7, 2026

FutureLife partners with Alife Health

FutureLife, a pan-European IVF and genetics provider, has rolled out an AI platform across its 60 clinics in 16 countries through a partnership with US-based Alife Health, which modernises and personalises the IVF process using AI.
May 7, 2026

HBI 2026: Investing in the UK and Ireland

A panel entitled ‘Investing in the UK and Ireland’ at HBI’s 2026 conference discussed how the healthcare market in the UK and Ireland is being shaped by policy shifts, which include the latest 10-year plan from the National Health Service (NHS). 
May 7, 2026

Nordic Capital-backed LEO Pharma buys Replay

Private equity firm Nordic Capital-backed LEO Pharma, a provider of medical dermatology solutions, has acquired gene therapy company Replay, which develops gene therapies for rare genetic conditions Replay’s equity holders will receive $50 million upfront, with additional milestone payments and tiered single-digit royalties.
May 7, 2026

Doctolib buys Medicus and enters the UK

European healthtech group Doctolib has entered the UK market through the acquisition of London-based startup Medicus. The company plans to invest over £100 million (~$136 million) in the UK as part of its expansion.
May 7, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us